Literature DB >> 21909344

The role of dendritic cells in viral persistence.

Cherie T Ng1, Brian M Sullivan, Michael B A Oldstone.   

Abstract

Viruses must modulate or suppress their host's immune system in order to persist. In this review, we discuss the means in which the lympocytic choriomenengitis virus targets and infects an essential component of the immune system, the dendritic cell, essential to bridging the innate and adaptive immune response. Infection of these cells results in pleiotropic effects that serve to deregulate the host immune response.

Entities:  

Mesh:

Year:  2011        PMID: 21909344      PMCID: PMC3167161          DOI: 10.1016/j.coviro.2011.05.006

Source DB:  PubMed          Journal:  Curr Opin Virol        ISSN: 1879-6257            Impact factor:   7.090


  61 in total

1.  Viral replicative capacity is the primary determinant of lymphocytic choriomeningitis virus persistence and immunosuppression.

Authors:  Andreas Bergthaler; Lukas Flatz; Ahmed N Hegazy; Susan Johnson; Edit Horvath; Max Löhning; Daniel D Pinschewer
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-22       Impact factor: 11.205

2.  PD-1:PD-L1 interactions contribute to the functional suppression of virus-specific CD8+ T lymphocytes in the liver.

Authors:  Holly Maier; Masanori Isogawa; Gordon J Freeman; Francis V Chisari
Journal:  J Immunol       Date:  2007-03-01       Impact factor: 5.422

3.  Interleukin-10 determines viral clearance or persistence in vivo.

Authors:  David G Brooks; Matthew J Trifilo; Kurt H Edelmann; Luc Teyton; Dorian B McGavern; Michael B A Oldstone
Journal:  Nat Med       Date:  2006-10-15       Impact factor: 53.440

4.  Virus-lymphocyte interactions. III. Biologic parameters of a virus variant that fails to generate CTL and establishes persistent infection in immunocompetent hosts.

Authors:  M B Oldstone; M Salvato; A Tishon; H Lewicki
Journal:  Virology       Date:  1988-06       Impact factor: 3.616

Review 5.  The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection.

Authors:  Arlene H Sharpe; E John Wherry; Rafi Ahmed; Gordon J Freeman
Journal:  Nat Immunol       Date:  2007-03       Impact factor: 25.606

6.  Restoring function in exhausted CD8 T cells during chronic viral infection.

Authors:  Daniel L Barber; E John Wherry; David Masopust; Baogong Zhu; James P Allison; Arlene H Sharpe; Gordon J Freeman; Rafi Ahmed
Journal:  Nature       Date:  2005-12-28       Impact factor: 49.962

7.  The primary structure of the lymphocytic choriomeningitis virus L gene encodes a putative RNA polymerase.

Authors:  M Salvato; E Shimomaye; M B Oldstone
Journal:  Virology       Date:  1989-04       Impact factor: 3.616

8.  Virus-lymphocyte interactions. IV. Molecular characterization of LCMV Armstrong (CTL+) small genomic segment and that of its variant, Clone 13 (CTL-).

Authors:  M Salvato; E Shimomaye; P Southern; M B Oldstone
Journal:  Virology       Date:  1988-06       Impact factor: 3.616

9.  Organ-specific selection of viral variants during chronic infection.

Authors:  R Ahmed; M B Oldstone
Journal:  J Exp Med       Date:  1988-05-01       Impact factor: 14.307

10.  Selection of genetic variants of lymphocytic choriomeningitis virus in spleens of persistently infected mice. Role in suppression of cytotoxic T lymphocyte response and viral persistence.

Authors:  R Ahmed; A Salmi; L D Butler; J M Chiller; M B Oldstone
Journal:  J Exp Med       Date:  1984-08-01       Impact factor: 14.307

View more
  14 in total

1.  A ceramide analogue stimulates dendritic cells to promote T cell responses upon virus infections.

Authors:  Curtis J Pritzl; Young-Jin Seo; Chuan Xia; Madhuvanthi Vijayan; Zachary D Stokes; Bumsuk Hahm
Journal:  J Immunol       Date:  2015-03-25       Impact factor: 5.422

Review 2.  Lessons learned and concepts formed from study of the pathogenesis of the two negative-strand viruses lymphocytic choriomeningitis and influenza.

Authors:  Michael B A Oldstone
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-22       Impact factor: 11.205

3.  Structure of the LCMV nucleoprotein provides a template for understanding arenavirus replication and immunosuppression.

Authors:  Brandyn R West; Kathryn M Hastie; Erica Ollmann Saphire
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2014-05-30

Review 4.  Alpha and Beta Type 1 Interferon Signaling: Passage for Diverse Biologic Outcomes.

Authors:  Cherie T Ng; Juan L Mendoza; K Christopher Garcia; Michael B A Oldstone
Journal:  Cell       Date:  2016-01-28       Impact factor: 41.582

5.  Type I Interferon Receptor Deficiency in Dendritic Cells Facilitates Systemic Murine Norovirus Persistence Despite Enhanced Adaptive Immunity.

Authors:  Timothy J Nice; Lisa C Osborne; Vesselin T Tomov; David Artis; E John Wherry; Herbert W Virgin
Journal:  PLoS Pathog       Date:  2016-06-21       Impact factor: 6.823

6.  Lymphocytic Choriomeningitis Virus Alters the Expression of Male Mouse Scent Proteins.

Authors:  Michael B A Oldstone; Brian C Ware; Amanda Davidson; Mark C Prescott; Robert J Beynon; Jane L Hurst
Journal:  Viruses       Date:  2021-06-21       Impact factor: 5.048

7.  Intact dendritic cell pathogen-recognition receptor functions associate with chronic hepatitis C treatment-induced viral clearance.

Authors:  Ian Gaël Rodrigue-Gervais; Hawley Rigsby; Loubna Jouan; Bernard Willems; Daniel Lamarre
Journal:  PLoS One       Date:  2014-07-17       Impact factor: 3.240

Review 8.  The role of viral persistence in flavivirus biology.

Authors:  Luwanika Mlera; Wessam Melik; Marshall E Bloom
Journal:  Pathog Dis       Date:  2014-05-12       Impact factor: 3.166

9.  Ancient Evolution of Mammarenaviruses: Adaptation via Changes in the L Protein and No Evidence for Host-Virus Codivergence.

Authors:  Diego Forni; Chiara Pontremoli; Uberto Pozzoli; Mario Clerici; Rachele Cagliani; Manuela Sironi
Journal:  Genome Biol Evol       Date:  2018-03-01       Impact factor: 3.416

10.  Population structure of Lassa Mammarenavirus in West Africa.

Authors:  Diego Forni; Manuela Sironi
Journal:  Viruses       Date:  2020-04-13       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.